mdl 72527 has been researched along with Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agostinelli, E; Arancia, G; Condello, M; Molinari, A; Tempera, G; Viceconte, N | 1 |
Agostinelli, E; Arancia, G; Belli, F; Condello, M; Marra, M; Molinari, A; Palmigiani, P; Seiler, N; Vedova, LD | 1 |
2 other study(ies) available for mdl 72527 and Melanoma
Article | Year |
---|---|
Cytotoxicity of spermine oxidation products to multidrug resistant melanoma M14 ADR2 cells: sensitization by the MDL 72527 lysosomotropic compound.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Lysosomes; Melanoma; Microscopy, Confocal; Microscopy, Electron, Transmission; Oxidation-Reduction; Putrescine; Spermine | 2009 |
Toxicity of enzymatic oxidation products of spermine to human melanoma cells (M14): sensitization by heat and MDL 72527.
Topics: Animals; Annexin A5; Cell Line, Tumor; Cell Survival; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Hot Temperature; Humans; Melanoma; Microscopy, Electron; Molecular Structure; Monoamine Oxidase; Oxidation-Reduction; Putrescine; Reactive Oxygen Species; Spermine; Time Factors | 2006 |